Pulse Biosciences, Inc. , a company leveraging its novel and proprietary nanosecond pulsed field ablation technology for the treatment of atrial fibrillation, today announced that it intends to. | May 10, 2023
Leading Cardiothoracic Surgeon Joins Leadership Team as the Company Leverages its Proprietary nsPFA™ Technology for the Treatment of Atrial Fibrillation
. | May 3, 2023
Pulse Biosciences, Inc (PLSE) Announces 10 02M Share Private Placement at $6 51/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary nanosecond pulsed field ablation technology and proprietary CellFX System® for the treatment of atrial fibrillation,. | May 1, 2023
Paragon 28 (NYSE:FNA – Get Rating) and Pulse Biosciences (NASDAQ:PLSE – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk and dividends. Profitability This table compares Paragon 28 and Pulse Biosciences’ […]